Trump's Executive Order Aims to Lower Prescription Drug Prices

Sun Jun 22 2025 03:09:35 GMT+0300 (Eastern European Summer Time)
Trump's Executive Order Aims to Lower Prescription Drug Prices

The new order targets price disparities, pushing drugmakers to reduce costs or face penalties.


In a significant move to combat high medication prices, President Trump has enacted an executive order compelling pharmaceutical companies to decrease their prices or risk alignment with international pricing frameworks.

The article text:

This week, President Donald Trump took a decisive action to reform the prescription drug market by signing an executive order that presents pharmaceutical companies with a clear choice: voluntarily cut drug prices or be compelled to align with the lowest prices set in other developed countries.

The newly minted order specifically addresses the price variations that have long placed American consumers at a disadvantage, imposing a 30-day deadline for drug manufacturers to implement significant price reductions. Should they neglect this ultimatum, the administration is prepared to advance a plan that would link the pricing of specific medications in the U.S. to the lowest international costs.

The Trump administration is framing this action as a crucial response to what it describes as exploitative pricing practices. For years, U.S. citizens have been burdened with exorbitant prices for the same medications that are available at much lower rates in nations like Canada or various European countries. Trump's vocal criticism of the pharmaceutical sector—regarded as one of the least accountable yet most powerful industries—has been a consistent theme throughout his time in office.

Proponents of the policy view it as both a necessary and responsible economic measure. With prescription prices escalating more steeply than wages, particularly harming seniors and low-income families, the frustration toward "Big Pharma" has been growing for decades. This executive order allows Trump to sidestep congressional inaction and takes a direct stand against a failing system.

However, the legality and effectiveness of the order have come under scrutiny, with critics voicing concerns about potential impacts on innovation in the pharmaceutical industry. White House representatives, nonetheless, assure that this executive decision is just the initial step in an ongoing reform process, hinting at further reforms that might include restructuring supply chains and enforcing transparency requirements.

For countless Americans who struggle to afford essential medications, this executive order could represent a pivotal shift in healthcare policy—and a significant milestone in the Trump administration's campaign against corporate overreach.

MORE ON THEME

Sat, 21 Jun 2025 21:15:14 GMT

Economic Forum Highlights Russia's Imminent Challenges Amid Ongoing Conflicts

Sat, 21 Jun 2025 21:15:14 GMT
Sat, 21 Jun 2025 11:12:23 GMT

Tulsi Gabbard Changes Stance on Iran's Nuclear Capability

Sat, 21 Jun 2025 11:12:23 GMT
Fri, 20 Jun 2025 23:35:37 GMT

NATO Summit: Trump Takes Center Stage Amidst Tensions and Spending Demands

Fri, 20 Jun 2025 23:35:37 GMT
Thu, 19 Jun 2025 20:55:25 GMT

**After the Strike: Eyewitness Accounts from the Soroka Hospital in Beersheba**

Thu, 19 Jun 2025 20:55:25 GMT
Thu, 19 Jun 2025 17:25:02 GMT

Escalating Tensions: The Israel-Iran Conflict Unfolds

Thu, 19 Jun 2025 17:25:02 GMT
Wed, 18 Jun 2025 22:26:01 GMT

Tehran's Tense Climate Fuels Evacuation Amid Ongoing Strikes

Wed, 18 Jun 2025 22:26:01 GMT
Wed, 18 Jun 2025 18:52:21 GMT

Fed Keeps Interest Rates Steady Amid Economic Uncertainties

Wed, 18 Jun 2025 18:52:21 GMT
Wed, 18 Jun 2025 04:39:50 GMT

G7 Summit Highlights: Trade, Tension, and Trump’s Exit

Wed, 18 Jun 2025 04:39:50 GMT
Tue, 17 Jun 2025 12:47:17 GMT

Starmer and Trump Seal Trade Deal Amid Windy Mishap

Tue, 17 Jun 2025 12:47:17 GMT
Tue, 17 Jun 2025 08:02:22 GMT

Trump Organization Ventures into Mobile Phone Market

Tue, 17 Jun 2025 08:02:22 GMT
Tue, 17 Jun 2025 02:13:51 GMT

Trump Organization Ventures into Smartphone Market

Tue, 17 Jun 2025 02:13:51 GMT
Mon, 16 Jun 2025 09:55:40 GMT

G7 Summit: Carney Faces Crucial Challenges in Kananaskis

Mon, 16 Jun 2025 09:55:40 GMT
Mon, 16 Jun 2025 00:55:20 GMT

Unpacking Trump's Investment Claims: What Lies Beneath the Numbers

Mon, 16 Jun 2025 00:55:20 GMT
Fri, 13 Jun 2025 18:38:37 GMT

Tensions Escalate: Israel Strikes Iran's Nuclear Sites Amid Retaliation Threats**

Fri, 13 Jun 2025 18:38:37 GMT
Fri, 13 Jun 2025 14:21:37 GMT

Trump's Peacemaking Legacy: Progress or Promise?

Fri, 13 Jun 2025 14:21:37 GMT
Fri, 13 Jun 2025 01:11:49 GMT

Tensions Escalate as Israel Strikes Iranian Nuclear Sites

Fri, 13 Jun 2025 01:11:49 GMT
Thu, 12 Jun 2025 23:32:31 GMT

Trump’s Second Term: A Review of His Peacekeeping Pledge

Thu, 12 Jun 2025 23:32:31 GMT
Thu, 12 Jun 2025 15:00:05 GMT

Curfew Continues in Los Angeles Amid Ongoing Protests Over Immigration Raids

Thu, 12 Jun 2025 15:00:05 GMT
Wed, 11 Jun 2025 11:32:38 GMT

Elon Musk Reflects on His Controversial Posts About Trump

Wed, 11 Jun 2025 11:32:38 GMT
Wed, 11 Jun 2025 11:29:10 GMT

Tensions Escalate in Los Angeles Amid Trump’s Controversial Military Deployment

Wed, 11 Jun 2025 11:29:10 GMT

Follow us

© 2024 SwissX REDD UK ltd. All Rights Reserved.